- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01208584
Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions
March 10, 2015 updated by: University Hospital, Basel, Switzerland
The purpose of this study is to use functional MRI (fMRI) and magnetic resonance (MR) diffusion tensor imaging (DTI) to investigate brain activation and white matter changes in patients with congenital (birth defect of the spinal column), acute and chronic complete spinal cord lesions.
The findings of this study may provide a basis to better understand the pathomechanisms underlying the dynamic neurofunctional changes following a spinal cord lesions in man.
This understanding is important for the improvement of existing therapies and for the development of new therapeutic approaches.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Recently new approaches to spinal cord repair have been successfully established in animal models.
Promising therapies for promoting spinal axonal regeneration in man will be available in the near future.
Most research in the field is focussed on the lesion itself and the perilesional spinal cord.
The recovery of motor and sensory function is,however, not permitted by local processes at the spinal level only.
The whole central nervous system (CNS) reacts to such a condition.
Therefore the modulation of motor and sensory function in spinal cord lesioned patients should be reflected in characteristic changes of cortical brain activity, which are accessible to new non-invasive functional neuroimaging techniques such as functional magnetic resonance imaging (fMRI).
Changes of white matter due to axonal damage can also be measured qualitatively and quantitatively using MR diffusion tensor imaging (DTI).
Those measures may provide a basis to better understand the pathophysiology underlying spinal cord lesions in man, including changes in brain function over time (during rehabilitation) or related to specific treatment.
However, there are no studies available yet addressing those topics or providing mechanism-based approaches for determining the time interval of application of novel neuroregenerative drugs.
By investigation of brain activation and white matter changes in patients with congenital(myelomeningocele (MMC)), acute and chronic spinal cord lesions (ASIA A) first and fundamental work in this field will be conducted in this study.
Study Type
Observational
Enrollment (Actual)
22
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Basle, Switzerland
- University Hospital, Basle (only study site!)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
- Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A
- Myelomeningocele patients (congenital paraplegia, thoracic level of lesion Th1-Th12) ASIA A
- Volunteers without any neurological deficits
Description
Inclusion criteria:
- Paraplegic patients (Th1-Th12, ASIA A),
- Myelomeningocele patients (Th1-Th12 ASIA A)
- Acute SCI 2-6 months, chronic SCI 12-24 months
Exclusion criteria:
- Traumatic brain injury (TBI)
- Neurological diseases other than spinal cord lesion
- MRI incompatibility
- Pressure sores
- methicillin-resistant Staphylococcus aureus (MRSA)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Chronic posttraumatic paraplegia
Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A, spinal cord injury (SCI) 12-24 months
|
functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)
|
|
Acute posttraumatic paraplegia
Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A,SCI 2-6 months,
|
functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)
|
|
Myelomeningocele patients
Myelomeningocele patients (congenital paraplegia, thoracic level of lesion Th1-Th12) ASIA A
|
functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)
|
|
Volunteers
Volunteers without any neurological deficits
|
functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Christoph Stippich, Prof, University Hospital, Basle - Department of Neuroradiology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2008
Primary Completion (Actual)
October 1, 2013
Study Completion (Actual)
October 1, 2013
Study Registration Dates
First Submitted
September 23, 2010
First Submitted That Met QC Criteria
September 23, 2010
First Posted (Estimate)
September 24, 2010
Study Record Updates
Last Update Posted (Estimate)
March 11, 2015
Last Update Submitted That Met QC Criteria
March 10, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 306/09
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myelomeningocele
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingNeural Tube Defects | Spina Bifida | Sacral MyelomeningoceleFrance
-
Assistance Publique - Hôpitaux de ParisUnité de Recherche Clinique Necker Cochin, FranceCompleted
-
University of Nove de JulhoUnknownMotor Activity | Myelomeningocele Without Hydrocephalus | Sensory Defect
-
Gaziantep City HospitalActive, not recruitingMyelomeningocele | Neonatal | Extubation TimeTurkey (Türkiye)
-
Bailey PetersenRecruiting
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Assiut UniversityNot yet recruitingMyelomeningocele
-
St. Louis UniversitySSM HealthTerminatedPregnancy | MyelomeningoceleUnited States
-
St. Louis UniversityTerminatedPregnancy | MyelomeningoceleUnited States
-
Superior UniversityActive, not recruitingMyelomeningocelePakistan
Clinical Trials on fMRI, DTI
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell UniversityCompletedBrain CancerUnited States
-
General Hospital of Ningxia Medical UniversityUnknownCharacterize and Evaluate Functional After Transplantation | Determine the Therapeutic Efficiency | Correlate the Imaging ResultsChina
-
Centre Paul StraussNot yet recruiting
-
Vanderbilt University Medical CenterVarian Medical SystemsCompletedDepression | Obsessive-Compulsive Disorder | Pain, IntractableUnited States
-
Centre Hospitalier St AnneAssistance Publique - Hôpitaux de Paris; National Research Agency, France; CENIR... and other collaboratorsUnknown
-
Xiangya Hospital of Central South UniversityUnknownPituitary Adenoma | Visual Impairment | Neuroimaging | Sellar TumorChina
-
Swiss Paraplegic Research, NottwilCompletedParalysis | Functional Neurological Symptom Disorder | Conversion Disorder with Weakness/ParalysisSwitzerland
-
Assiut UniversityRecruitingSensorineural Hearing LossEgypt
-
M.D. Anderson Cancer CenterDirect TherapeuticsCompletedGlioma | Brain NeoplasmsUnited States